WASHINGTON: In a major geopolitical development, US President Donald Trump has identified India, China, and Pakistan among 23 countries designated as major drug transit or illicit drug-producing nations. The designation was formally submitted to the US Congress via an official Presidential Determination.
Despite placing these countries on the global radar, President Trump clarified that inclusion on the list does not automatically reflect a government’s current counterdrug shortcomings or a lack of coordination with the United States. According to the administration, nations are often added due to a combination of distinct geographic, commercial, and economic conditions that allow drug transit or precursor chemical production to take place, even when governments enforce robust and diligent law enforcement and narcotics control measures.
Highlighting India's proactive stance, Trump specifically acknowledged New Delhi's efforts. “I welcome Prime Minister Modi and the Government of India's efforts to address illicit opium poppy cultivation and bolster supply chain integrity. I look forward to continued cooperation through the United States-India Drug Policy Framework,” he stated.
Alongside India, China, and Pakistan, the comprehensive list of 23 major drug transit or illicit drug-producing countries features Afghanistan, The Bahamas, Belize, Bolivia, Burma, Colombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Laos, Mexico, Nicaragua, Panama, Peru, and Venezuela.
The annual designation serves to keep Washington focused on global narcotics supply chains and encourages ongoing collaborative counter-narcotics frameworks with international partners.
